Skip to main content
80°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
March 08, 2024
Tags
Tesla Inc
Pharmaceuticals
Europe News
From
CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
March 07, 2024
Tags
Eli Lilly and Co
Investing
Markets
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
Tags
Pharmaceuticals
US: News
Eli Lilly and Co
From
CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
March 04, 2024
Tags
Markets
stocks
Eli Lilly and Co
From
CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
March 03, 2024
Tags
Viking Therapeutics Inc
Biotech and Pharmaceuticals
Breaking news
From
CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
March 01, 2024
Tags
Markets
Goldman Sachs BDC Inc
Europe News
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 29, 2024
Tags
Snowflake Inc/
Investment strategy
5 Things to Know
From
CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
February 29, 2024
Tags
Markets
Prices
Eli Lilly and Co
From
CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
February 28, 2024
Tags
Asia Markets
S&P Global Inc
Europe Markets
From
CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
Tags
Weight loss diets
CNBC Changemakers
Diets and dieting
From
CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
February 28, 2024
Tickers
CATS
DOGS
PETS
Tags
CNBC Changemakers
Cats
Animals
From
CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
February 27, 2024
Tags
Zealand Pharma A/S
Health care industry
Health & Science
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
Retail
Breaking News: Business
Goldman Sachs Group Inc
From
CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
February 26, 2024
Tags
Zealand Pharma A/S
Novo Nordisk A/S
Breaking News: Markets
From
CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
Tags
Employee healthcare benefits
Personnel
Pharmaceuticals
From
CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
Tags
Business News
Pfizer Inc
Biotechnology
From
CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
February 06, 2024
Tags
Business News
Science
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
February 05, 2024
Tags
Breaking news
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
January 31, 2024
Tags
Europe Markets
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Starbucks Corp
General Motors Co
Business News
From
CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
Tags
Health care industry
Companies
Health & Science
From
CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Tags
Viking Therapeutics Inc
Biotech and Pharmaceuticals
Breaking news
From
CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
January 08, 2024
Tags
Novo Nordisk A/S
Compute Health Acquisition Corp
Mondelez International Inc
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Bristol/Myers Squibb Co
Johnson & Johnson
US: News
From
CNBC.com News
Here are the big health sector themes to watch next year
December 22, 2023
Tags
stocks
Abbott Laboratories
UnitedHealth Group Inc
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Biotech and Pharmaceuticals
Business
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Monday
December 18, 2023
Tags
Economy
Investment strategy
5 Things to Know
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Business News
Pfizer Inc
Novo Nordisk A/S
From
CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
December 11, 2023
Tags
Eli Lilly and Co
Pharmaceuticals
US: News
From
CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
December 05, 2023
Tags
Companies
Health & Science
Health care industry
From
CNBC.com News
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.